The campaign is focused on empowering patients with lung cancer and their caregivers to initiate a dialogue with their physicians about comprehensive genomic testing and its potential to expand treatment options for the patient.
Read More
New probes facilitate the diagnosis and stratified treatment of non-small cell lung cancer.
Read MoreAn international group of lung cancer experts has announced the public comment period for a revised guideline on molecular testing to improve patient selection and targeted therapies.
Read MoreStudy demonstrates the test’s potential as a clinical tool for identifying patients who can benefit from drugs targeting specific mutations.
Read More
University of Missouri study identifies more precise probability of cancer diagnosis.
Read More